Similar articles

• [Percentage of concanavalin-A non-conjugating alpha-fetoprotein in amniotic fluid in the prenatal diagnosis of neural tube defects].

  Meng JP. Meng JP. Zhonghua Fu Chan Ke Za Zhi. 1988 May;23(3):139-41, 188. Zhonghua Fu Chan Ke Za Zhi. 1988. PMID: 2461841 Chinese. No abstract available.
• Clinical applications of alpha-fetoprotein determinations.

  Ainbender E, Brown E, Kierney C, Hirschhorn K. Ainbender E, et al. UCLA Forum Med Sci. 1978;20:169-78. UCLA Forum Med Sci. 1978. PMID: 80858 No abstract available.
• Screening for fetal neural tube defects: rationale and experience.

  Brock DJ. Brock DJ. Prog Clin Biol Res. 1982;103 Pt B:461-72. Prog Clin Biol Res. 1982. PMID: 6187021 No abstract available.
• [Prenatal diagnosis of neural tube defects].

  Agosti S, Brambati B, Cucconi T, Mariani V. Agosti S, et al. Pediatr Med Chir. 1982 Jan-Apr;4(1-2):71-7. Pediatr Med Chir. 1982. PMID: 6180415 Review. Italian. No abstract available.
• Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.

  Haddow JE. Haddow JE. Semin Perinatol. 1990 Dec;14(6):488-503. Semin Perinatol. 1990. PMID: 1706536 Review. No abstract available.